Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

229.98 +0.09 (+0.04%)

Official Closing Price Updated: 7:00 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

91 92 Next >

Is AbbVie a Buy, Sell, or Hold in 2026? ↗

December 27, 2025

It is wrapping up another great year, and there is no sign of a slowdown.

Via The Motley Fool

Topics Intellectual Property

The Best Stocks to Invest $50,000 in Right Now ↗

December 27, 2025

If you're investing for the long run, there are a myriad of companies begging to be bought.

Via The Motley Fool

Topics Artificial Intelligence

The Vaccine Vanguard: Inside Sanofi’s $2.2 Billion Strategic Bet on Dynavax

December 25, 2025

As 2025 draws to a close, the global pharmaceutical landscape has been reshaped by a series of aggressive consolidations and strategic pivots. At the center of this transformation is Sanofi (NASDAQ:...

Via PredictStreet

Topics Artificial Intelligence Economy Intellectual Property

Top 5 US Healthcare Stocks By Market Value ↗

December 24, 2025

Weight-loss drugs, drug-pricing reforms, and legal challenges have reshaped the U.S. healthcare landscape in 2025.

Via Stocktwits

The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave

December 23, 2025

As the biotech sector closes out a transformative 2025, one name has risen to the top of every institutional investor's watchlist: Abivax (NASDAQ: ABVX). Following a year of stellar clinical results...

Via MarketMinute

Topics Intellectual Property

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

December 22, 2025

Investors can expect steady dividend returns with these stocks.

Via The Motley Fool

Topics Intellectual Property

3 Dividend Growth Stocks Analysts Are Upgrading for 2026 ↗

December 21, 2025

Via MarketBeat

AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report ↗

December 19, 2025

This comes after President Donald Trump urged drugmakers in July to lower drug prices for the U.S. government’s Medicaid program.

Via Stocktwits

Topics Economy Government

This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗

December 19, 2025

This top-shelf exchange-traded fund (ETF) checks all the right boxes for income- and value-seeking investors.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

Want $10,000 in Passive Income? This Vanguard ETF Could Be Your Ticket to Making It Happen. ↗

December 18, 2025

Investors would need to have over $330,000 invested in this Vanguard dividend ETF.

Via The Motley Fool

Topics ETFs Stocks

Is AbbVie a Millionaire Maker? ↗

December 18, 2025

AbbVie's third-quarter earnings were disappointing, but the company raised its full-year guidance and increased the dividend.

Via The Motley Fool

Topics Intellectual Property

Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market. ↗

December 18, 2025

The stocks listed here were all up more than 19% in 2022, while the S&P 500 crashed.

Via The Motley Fool

Topics Intellectual Property Stocks

The Yield Search: Why Retirees are Swapping Growth for Defense in a Shifting 2025 Market

December 18, 2025

As of December 18, 2025, the financial landscape is undergoing a significant transformation, forcing retirees to reconsider their high-octane growth strategies in favor of more stable,...

Via MarketMinute

Topics Artificial Intelligence Bonds ETFs

Want Decades of Passive Income? Buy This ETF and Hold It Forever. ↗

December 17, 2025

Can one ETF deliver decades of dividend income? This unique high-quality yield generator deserves a spot on your watchlist.

Via The Motley Fool

Topics ETFs Stocks

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗

December 17, 2025

The potential agreements would mark another step in Washington’s broader effort to reshape drug pricing.

Via Stocktwits

Topics Government World Trade

My Top 3 Healthcare Stocks to Buy in 2026 ↗

December 13, 2025

These habitual market beaters can pull it off again.

Via The Motley Fool

Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 ↗

December 12, 2025

They could grow into their valuation over the next few years.

Via The Motley Fool

Topics Intellectual Property

Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul ↗

December 12, 2025

Via MarketBeat

The Smartest Dividend Stocks to Buy With $5,000 Right Now ↗

December 12, 2025

See what solid dividends do for a portfolio after just five years.

Via The Motley Fool

Topics Retirement

2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore

December 11, 2025

Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing...

Via StockStory

Is AbbVie Stock Too Cheap to Ignore at Today's Price? ↗

December 11, 2025

The drugmaker has plenty to offer investors.

Via The Motley Fool

Topics Intellectual Property

Guardian Wealth Doubles Down on LKQ Stock With $1.8 Million Purchase, According to Recent SEC Filing ↗

December 10, 2025

Guardian Wealth Management raised its stake in LKQ stock to nearly $4.9 Million during the third quarter of 2025.

Via The Motley Fool

Topics Regulatory Compliance

Guardian Wealth Takes $5.1 Million Stake in Viper Energy, According to Recent SEC Filing ↗

December 10, 2025

Guardian Wealth bought over 133,000 shares of Viper Energy during the third quarter of 2025.

Via The Motley Fool

Topics Energy Regulatory Compliance

Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution

December 09, 2025

New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index...

Via MarketMinute

Topics ETFs Economy Intellectual Property

1 Major Factor Behind the Healthcare Sector's Recent Surge ↗

December 09, 2025

Blockbuster drugs are a major driver of the growth of healthcare stocks.

Via The Motley Fool

3 Top Dividend Stocks to Buy in December ↗

December 09, 2025

Great dividends are only part of the attraction with these stocks.

Via The Motley Fool

Topics Initial Public Offering Intellectual Property

The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. ↗

December 06, 2025

This drugmaker has a strong portfolio of best-selling drugs and a growing pipeline.

Via The Motley Fool

Topics ETFs

Could Buying AbbVie Today Set You Up for Life? ↗

December 04, 2025

Don't bet against it.

Via The Motley Fool

Topics Intellectual Property Lawsuit

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

These ETFs can provide me with lots of passive income.

Via The Motley Fool

Topics ETFs Stocks

Morgan Stanley Downgrades Regeneron (REGN) to Equal-Weight, Citing Fair Valuation and Pipeline Scrutiny

December 03, 2025

New York, NY – December 3, 2025 – In a significant move reverberating through the biotechnology sector, investment banking giant Morgan Stanley has downgraded Regeneron Pharmaceuticals (NASDAQ: REGN)...

Via MarketMinute

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

91 92 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.